|
Insider Trading: ARIAD PHARMACEUTICALS INC
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of ARIAD PHARMACEUTICALS INC in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of ARIAD PHARMACEUTICALS INC since year 2005. Table 2 shows the detailed insider transactions of ARIAD PHARMACEUTICALS INC since 2005.
The reporting company's ticker symbol is ARIA.
The reporting company's CIK number is 884731.
The total value of stock buying since 2005 is $0.
The total value of stock sales is $235,537.
The total value of stock exercises is $1,455,963.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at ARIAD PHARMACEUTICALS INC (ARIA) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at ARIAD PHARMACEUTICALS INC (ARIA) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for ARIAD PHARMACEUTICALS INC (ARIA).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-01 | 0 | 0 | 0 | 0 | 40,000 | 0 |
| 2007-07 | 0 | 0 | 0 | 0 | 113,772 | 497,860 |
| 2007-06 | 0 | 0 | 0 | 0 | 85,000 | 258,399 |
| 2007-05 | 0 | 0 | 0 | 0 | 224,455 | 448,910 |
| 2007-01 | 0 | 0 | 0 | 0 | 10,000 | 0 |
| 2006-03 | 0 | 0 | 0 | 0 | 25,933 | 108,334 |
| 2006-02 | 0 | 0 | 26,077 | 170,538 | 34,000 | 142,460 |
| 2006-01 | 0 | 0 | 10,000 | 64,999 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for ARIAD PHARMACEUTICALS INC (ARIA)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-01-18 | Lamarche Jay R (Director) | Option Exercise | 10,000 | .00 | 0 |
| 2008-01-18 | Kishbauch Michael D (Director) | Option Exercise | 10,000 | .00 | 0 |
| 2008-01-17 | Lamarche Jay R (Director) | Option Exercise | 10,000 | .00 | 0 |
| 2008-01-17 | Sobel Burton E (Director) | Option Exercise | 10,000 | .00 | 0 |
| 2007-07-11 | Clackson Timothy P (SrVP, Chief Scientific Officer) | Option Exercise | 6,400 | 5.06 | 32,403 |
| 2007-07-09 | Berger Harvey J M D (Chairman and CEO) | Option Exercise | 107,372 | 4.34 | 465,457 |
| 2007-06-28 | Wyatt Elizabeth H S (Director) | Option Exercise | 40,000 | 3.36 | 134,200 |
| 2007-06-20 | Smith Sandford D (Director) | Option Exercise | 45,000 | 2.76 | 124,199 |
| 2007-05-17 | Berger Harvey J M D (Chairman & Chief Exec Officer) | Option Exercise | 224,455 | 2.00 | 448,910 |
| 2007-01-17 | Kishbauch Michael D (Director) | Option Exercise | 10,000 | .00 | 0 |
| 2006-03-10 | Iuliucci John D (Senior VP, Chief Dev. Off.) | Option Exercise | 2,633 | 4.19 | 11,032 |
| 2006-03-10 | Clackson Timothy P (SVP, Chief Scientific Officer) | Option Exercise | 1,300 | 3.94 | 5,122 |
| 2006-03-10 | Berger Harvey J M D (Chairman and CEO) | Option Exercise | 22,000 | 4.19 | 92,180 |
| 2006-02-15 | Lamarche Jay R (Director) | Sale | 777 | 6.51 | 5,058 |
| 2006-02-15 | Lamarche Jay R (Director) | Option Exercise | 34,000 | 4.19 | 142,460 |
| 2006-02-14 | Lamarche Jay R (Director) | Sale | 25,300 | 6.54 | 165,480 |
| 2006-01-18 | Sobel Burton E (Director) | Sale | 4,147 | 6.50 | 26,955 |
| 2006-01-09 | Sobel Burton E (Director) | Sale | 5,853 | 6.50 | 38,044 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of ARIAD PHARMACEUTICALS INC (symbol ARIA,
CIK number 884731) see
the Securities and Exchange Commission (SEC) website.
|
|
